The major risk factor for intrapartum uterine rupture is a previous cesarean delivery. This study aimed to ascertain the rate of uterine rupture in a trial of labor after cesarean section in women with and without prior vaginal birth STUDY DESIGN: Electronic medical records of trials of labor after one previous cesarean section between the years 2003-2015 were reviewed. We included singleton deliveries at 24 weeks with vertex presentation.
778 Off-label use of Dinoprostone in women after 3 deliveries or more: efficacy and safety OBJECTIVE: According to the manufacture instructions, a history of 3 deliveries or more is a contraindication for the use of dinoprostone vaginal insert for induction of labor. The aim of this study was to determine the efficacy and safety of labor induction with dinoprostone slow release vaginal insert in women with history of 3 deliveries or more. STUDY DESIGN: A retrospective cohort study of all pregnant women who underwent induction of labor with dinoprostone slow release vaginal insert in single tertiary care center. The study group included women with history of 3 deliveries or more and the control group included women with history of 2 vaginal deliveries or less. Insertion-to-delivery time, the rate of delivery within 24 hours, as well as the rates of Cesarean section, maternal and neonatal complication were determined in both groups. Non-parametric statistics were used for analysis. RESULTS: During the study period, 449 women were admitted for induction with dinoprostone slow release vaginal insert. Thirty three (7.3%) had 3 deliveries and 416 (92.7%) had less than 3 deliveries at admission. There were no significant differences in the median gestational age, BMI, GCT, birth weight and in the rate of chronic hypertension and gestational diabetes mellitus. As expected, maternal age was higher in the study group compared to controls (median 36; IQR 31-37 years vs. 31; IQR 28-36 years, respectively, p¼0.001). Cervical dilatation was also greater in the study group compared to controls (1; IQR: 0-1.5 cm vs. 0; IQR: 0-1 cm, respectively, p¼0.004).The insertion-to-delivery time was significantly shorter in the study group compared to controls (15.9; IQR: 9.4-34.5 hours vs. 28.8; IQR:15.9-47.9 hours, respectively, p¼0.02). Similarly, the rate of delivery within 24 hours was also higher in the study group compared to controls (66.7% vs. 46.9%, respectively, p¼0.03). There was no significant differences between study and control group in the rate of Cesarean section (12.1% vs. 18%) instrumental delivery (7.7% vs. 0%) or Apgar score. Regression analysis revealed that cervical dilatation (p¼0.27) but not parity was significantly associated with insertion-to-delivery interval after adjustment for fetal head station, maternal age and birth weight. CONCLUSION: Dinoprostone slow release vaginal insert is an efficient and safe method for induction of labor in women who had more than three deliveries.
779 National implementation of a decision aid/ prediction model on practice variation, VBAC and adverse outcome 
OBJECTIVE:
In the Netherlands about 66% of the women with one prior caesarean starts a trial of labor. However, this varies from 46-94% and a negative relation between TOL and actual VBAC is observed. This large practice variation was irrespective of individual risk profiles. In the SIMPLE II we showed that a decision aid with a prediction model resulted in a shift from unplanned to planned CS without an effect on the VBAC rates. The aim of this implementation study is to study practice variation in vaginal birth after caesarean after nationwide implementation of the decision aid including a validated prediction model. Secondary outcome is the adverse outcome rate. STUDY DESIGN: A multicentre cohort study was performed in 30 Dutch hospitals before (2013) and after (2017-2018) the introduction of the patient decision aid. A total of 1500 women with one prior caesarean section without a contraindication for a trial of labour were included. RESULTS: Overall the practice variation reduced after the implementation of the patient decision aid. A reduction with a factor 1.5 was seen for planned CS rate (p¼0.351). The practice variation for vaginal birth reduced with a factor 1.9 (p¼0.125). The variation in unplanned CS rate was reduced with a factor 1.55 (p¼0.351). Table 1 shows mode of delivery and complication rates before and after the introduction. There was no significant difference in amount of women with a TOL (66.3% vs 61.5% (p¼0.082), but the number of women with VBAC reduced from 48.3% to 41.% (p¼0.012).
However, a 30% reduction was seen in the composite adverse outcome for foetal and maternal complications (p¼ 0.01). 
The objective of the study was to verify the appearance of signs of suspected Triple I and the progressive involvement of placenta according to Redline classification of chorionamnionitis (CHA) and to understand the impact of CHA on maternal and neonatal outcome STUDY DESIGN: A retrospective cohort study of histological placental analysis obtained after term pregnancies between 2014-2017 at Carate Brianza Hospital, University of Milano-Bicocca. Included were all cases of HCA. The diagnosis of maternal fever (T ) and suspected intraamniotic inflammation, infection or both was made according to Triple I classification (IAI). Maternal adverse outcomes were defined as postpartum haemorrhage, endometritis or composite bad outcome (Mbad) including fever after hospital discharge and/or prolonged antibiotic therapy. Neonatal adverse outcomes were defined as asphyxia, positive blood culture, high CRP or composite bad outcome (Nbad) including admission to NICU and/ or prolonged antibiotic therapy. Histological CHA was stadiated for severity according to Redline classification. Analyses were conducted by SPSSÒ 24.0; p-value <0.05 was considered significant RESULTS: Among 6,962 deliveries, 1,314 placentas of which 1,122 at term, were analysed, 32.4 % due to signs of IAI in labour . 339 of placentas had HCA and 133 (39.2%) of them had a whole inflammatory involvement (PLw). The presence of T plus all 3 other clinical signs of IAI (all T ) was significantly related to stage 1 (p<0.01), stage 2 (p<0.05) of maternal inflammatory placental involvement (PLm) moreover to stage 1 (p<0.01), stage 2 (p<0.02), stage 3 (p<0.01) of fetal inflammatory placental involvement (PLf).
PLw was significantly related to all T (p<0.028). Signs of IAI plus HCA was related at univariate and multivariate analysis to Mbad (OR 7.12, p < 0.008). Endometritis (p < 0.03) and Mbad (p < 0.02) were related to PLw. High CRP (p < 0.001) and positive blood neonatal culture (p < 0.001) were related to PLf 
The evidence regarding obstetric and neonatal outcomes in trial of labor after cesarean (TOLAC) was established prior to the institution of contemporary labor management. Our objective was to evaluate obstetric and neonatal outcomes in women attempting TOLAC with 2 prior cesareans compared with those with a history of 1 previous cesarean since the advent of a contemporary labor curve. STUDY DESIGN: This was a retrospective cohort study of women attempting vaginal birth after cesarean (VBAC) with 1 and 2 prior cesarean deliveries between January 2011-May 2018 at an academic tertiary care center. Women with viable, non-anomalous singleton gestations were included. The primary outcome was VBAC success. Secondary outcomes were composite maternal and neonatal adverse outcomes (Table 2) . Univariate analysis was performed using Chisquared, X tests and Fisher's exact tests. Odds ratios (OR) were calculated for maternal and fetal outcomes according to number of prior cesareans. RESULTS: Of 1302 women attempting TOLAC who met inclusion criteria, 1156 (88.8%) women had 1 prior cesarean and 146 (11.2%) had 2 prior cesarean deliveries. Women attempting TOLAC were found to be similar with regard to race, baseline body mass index (BMI), delivery BMI, diabetes, hypertension, and tobacco use (p <0.05 for all). Women with 2 prior cesareans had more frequent history of prior cesarean for labor arrest (39 vs. 29%, p ¼ .01) and lower birth weight in the current pregnancy (3260g vs. 3187g, p ¼ .03). Women with 1 prior cesarean had higher rates of VBAC (75%) than those with 2 prior cesareans (66%) (OR 0.64, 95% CI 0.44-0.92, P¼0.016). Women with 2 prior cesareans are more likely to experience postpartum hemorrhage (11.9% vs. 17.8%, OR ¼ 1.6, CI 1.01-2.53, P¼.04) and ICU admission (0.3% vs. 1.4%, OR¼ 5.3, CI 0.9-32, P¼0.04) but both maternal and neonatal composites outcomes were not different between groups (Table 2) . CONCLUSION: Women with 2 prior cesareans had lower VBAC success than those with 1 prior cesarean, but most women attempting TOLAC in both groups were successful. Uterine rupture and maternal composite morbidity was similar between women with 2 prior and 1 prior cesarean deliveries, but those with 2 cesareans had
